Medicines rebate agreement for betamethasone and salicylic acid

Summary

The tender concerns the conclusion of a non-exclusive rebate agreement for medicines containing the active substances betamethasone and salicylic acid for the period 1 July 2026 to 30 June 2028, with an option to extend it once by 12 months. DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible. The machine-readable notice did not include precise qualification or exclusion requirements; these must be checked in the tender documents.